Hearing Loss News and Research RSS Feed - Hearing Loss News and Research

Hearing loss, impairment or deafness may be of two major types: one that develops some time in life, one that a baby is born with – or congenital deafness. Most commonly, hearing loss is seen with age or is caused by exposure to loud noises.
Proton beam therapy safe for treating childhood brain cancer medulloblastoma

Proton beam therapy safe for treating childhood brain cancer medulloblastoma

Proton beam therapy--a more precise form of radiotherapy--to treat the childhood brain cancer medulloblastoma appears to be as safe as conventional radiotherapy with similar survival rates, according to new research published in The Lancet Oncology journal today. [More]
Proton radiotherapy as effective as standard photon therapy in treating pediatric brain tumor

Proton radiotherapy as effective as standard photon therapy in treating pediatric brain tumor

The use of proton radiotherapy to treat the most common malignant brain tumor in children is as effective as standard photon (x-ray) radiation therapy while causing fewer long-term side effects such as hearing loss and cognitive disorders, according to a study receiving online publication in Lancet Oncology. [More]
Hearing aids improve brain function in people with hearing loss

Hearing aids improve brain function in people with hearing loss

A recent study by Jamie Desjardins, Ph.D., an assistant professor in the speech-language pathology program at The University of Texas at El Paso, found that hearing aids improve brain function in persons with hearing loss. [More]
Four USF professors selected as AIMBE College of Fellows

Four USF professors selected as AIMBE College of Fellows

Four University of South Florida professors have been elected to the 2016 College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE): Cesario Borlongan and Shyam Mohapatra from the USF Morsani College of Medicine, USF Health; and Robert Frisina, Jr., and Sudeep Sarkar from the USF College of Engineering. [More]
Strathspey Crown Holdings announces acquisition of Novus Via assets

Strathspey Crown Holdings announces acquisition of Novus Via assets

Strathspey Crown Holdings LLC announced today the acquisition of the portfolio companies of Novus Via LP, a Nevada-based venture capital investment firm focused on end-stage development and commercialization of advanced electromagnetic and electrochemical technologies spanning healthcare, clean energy and coherent acoustics. The terms of the transaction were not disclosed. [More]
FDA-approved, once-daily 24-hour aspirin now available for prevention of stroke and acute cardiac events

FDA-approved, once-daily 24-hour aspirin now available for prevention of stroke and acute cardiac events

New Haven Pharmaceuticals, Inc. today announced the availability by prescription of DURLAZA, the first and only 24-hour, extended-release aspirin capsules (162.5mg) approved by the U.S. Food and Drug Administration (FDA) for the secondary prevention of stroke and acute cardiac events, including myocardial infarction (heart attack) in high-risk cardiovascular patients. [More]
CAMH researchers identify 428 distinct disease conditions that co-occur in people with FASD

CAMH researchers identify 428 distinct disease conditions that co-occur in people with FASD

Researchers at the Centre for Addiction and Mental Health have identified 428 distinct disease conditions that co-occur in people with Fetal Alcohol Spectrum Disorders (FASD), in the most comprehensive review of its kind. [More]
FDA permits Sound Pharmaceuticals to start SPI-1005 clinical trial for treatment of Meniere's Disease

FDA permits Sound Pharmaceuticals to start SPI-1005 clinical trial for treatment of Meniere's Disease

Sound Pharmaceuticals is pleased to announce that it began enrolling a clinical trial to test SPI-1005 in the treatment of Meniere's Disease (MD). MD or idiopathic endolymphatic hydrops is an inner ear disease that involves episodic vertigo, sensorineural hearing loss, and tinnitus. [More]
Premature triplets released from Loyola University Medical Center in time for first Christmas

Premature triplets released from Loyola University Medical Center in time for first Christmas

Triplets Finn, Kyle and Ava Santiago, who were born six weeks premature and underweight, went home from Loyola University Medical Center Dec. 24, just in time to celebrate their first Christmas. [More]
New study reveals why some vestibular schwannomas cause hearing loss

New study reveals why some vestibular schwannomas cause hearing loss

A new study at Massachusetts Eye and Ear showed that in some cases of vestibular schwannoma, a sometimes-lethal tumor often associated with neurofibromatosis 2 (NF2), secretions from the tumor contain toxic molecules that damage the inner ear. [More]
New study reveals link between tinnitus severity and emotion processing in the brain

New study reveals link between tinnitus severity and emotion processing in the brain

Tinnitus, otherwise known as ringing in the ears, affects nearly one-third of adults over age 65. The condition can develop as part of age-related hearing loss or from a traumatic injury. In either case, the resulting persistent noise causes varying amounts of disruption to everyday life. [More]

New prosthesis brings hope to patients with hearing loss

A new prosthesis for a traditional ear surgery is bringing hope to patients diagnosed with a hereditary disorder that causes hearing loss. After 63-year-old Diane Duncan was diagnosed with otosclerosis in her thirties, she transitioned into an isolated world where conversations with other people became limited, everyday noises like car engines running and cell phones ringing became almost inaudible. [More]
Experts list top 10 research priorities for tackling hearing loss

Experts list top 10 research priorities for tackling hearing loss

Experts have published a list of the most urgent priorities for researching a debilitating condition that affects more than 10 million people in the UK. [More]
CRISPR tool unlocks potential for novel treatments across different therapeutic areas

CRISPR tool unlocks potential for novel treatments across different therapeutic areas

CRISPR is one of the most exciting advances in gene-based medicine in decades. A uniquely powerful tool for editing the genome, it allows scientists to manipulate DNA with unprecedented precision by deleting unwanted or faulty genes and replacing them with different ones. Its promise in this field of medicine is immense, unlocking the potential for novel treatments across a wide range of therapeutic areas. [More]
Sound deprivation causes irreversible damage to the inner ear

Sound deprivation causes irreversible damage to the inner ear

Massachusetts Eye and Ear investigators have shown that sound deprivation in adult mice causes irreversible damage to the inner ear. The findings, published in PLOS ONE, suggest that chronic conductive hearing loss, such as that caused by recurrent ear infections, leads to permanent hearing impairment if it remains untreated. [More]
New Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours

New Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours

New Haven Pharmaceuticals, Inc. today announced new study data that shows the company's FDA-approved drug DURLAZA delivers sustained antiplatelet control for a full 24-hour period in high-risk patients. [More]
Inner ear damage brain warnings from nerve cells

Inner ear damage brain warnings from nerve cells

Some nerve cells in the inner ear can signal tissue damage in a way similar to pain-sensing nerve cells in the body, according to new research from Johns Hopkins. [More]
Genetic reduction of AMPK enzyme can prevent or delay hearing loss

Genetic reduction of AMPK enzyme can prevent or delay hearing loss

A mitochondrial defect is responsible for a type of human hereditary deafness that worsens over time and can lead to profound hearing loss. [More]
Chemotherapy treatment can contribute to long-term neurocognitive deficits in pediatric brain tumor survivors

Chemotherapy treatment can contribute to long-term neurocognitive deficits in pediatric brain tumor survivors

More children are surviving malignant brain tumors than in the past, thanks to the use of intense treatments using platinum-based chemotherapy (cisplatin and high-dose carboplatin). Unfortunately, the therapy has a known side effect of permanent hearing loss, resulting from damage to the inner ear. [More]

Cochlear implants improve outcomes in infants with profound hearing loss

'Dada' is a first word for many babies. Babbling sounds with consonant-vowel repetitions, such as 'dada,' are common among infants once they reach 8 months old; however, these sounds are not prevalent among infants who have profound hearing loss -- that is, until they receive cochlear implants. [More]
Advertisement
Advertisement